Cite
MLA Citation
Ke Chen et al.. “Efficacy and safety of addition of bevacizumab to FOLFIRI or irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer.” Medicine, vol. 95, no. 46, 2016, pp. e5221–. http://access.bl.uk/ark:/81055/vdc_100039329069.0x000022